MYC and angiosarcoma: Co-immunostaining was carried out with an anti-VE-cadherin antibody, in order to identify the angiosarcoma or pyogenic granuloma cells in transformed lesions33, along with anti-c-Myc, FoxO1, aPKCλ, or pSer218-FoxO1 antibodies.